DescriptionAn interdisciplinary and multinational group of specialists present contributions describing the current status of vaccines against virally induced tumors and discuss the means by which they can be improved.
Human T Cell Lymphotropic Virus: Necessity for and Feasibility of a Vaccine.
Hepatitis B Virus Infection, the Immune Response and Hepatocellular Carcinoma.
Assembly and Transport of Class I MHC-Peptide Complexes.
Propagation of Mouse and Human T Cells with Defined Antigen Specificity and Function.
Bone Marrow-Derived Cells Present MHC Class I-Restricted Tumour Antigens in Priming of Antitumour Immune Responses.
Evasion of Host Immune Responses by Tumours and Viruses.